Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Treprostinil diethanolamine

EU orphan designation number: EU/3/09/635   
Active ingredient: Treprostinil diethanolamine
Indication: Treatment of systemic sclerosis
Sponsor: United Therapeutics Europe Ltd
59-61 Guildford Street, Chertsey, Surrey KT16 9BA, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
20/05/2009 Centralised Orphan - Designation EMEA/OD/106/08 (2009)4060 of 15/05/2009